Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
44.05
1.26 (2.94%)
At close: May 08, 2025, 1:14 PM
2.94% (1D)
| Bid | 43.99 |
| Market Cap | 3.51B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -252.06M |
| EPS (ttm) | -3.75 |
| PE Ratio (ttm) | -11.75 |
| Forward PE | -9.08 |
| Analyst | Strong Buy |
| Ask | 44.16 |
| Volume | 363,947 |
| Avg. Volume (20D) | 1,246,567.9 |
| Open | 43.07 |
| Previous Close | 42.79 |
| Day's Range | 41.95 - 44.48 |
| 52-Week Range | 17.86 - 58.40 |
| Beta | -0.13 |
About AKRO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKRO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+97.52%
Akero Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
